Article

Hormone therapy in hypospadias surgery: A systematic review

Federal University of Juiz de Fora - UFJF, Av. Rio Branco, 2985/sl. 605, Juiz de Fora, MG 36010012, Brazil. Electronic address: .
Journal of pediatric urology (Impact Factor: 1.41). 04/2013; 9(6). DOI: 10.1016/j.jpurol.2013.03.009
Source: PubMed

ABSTRACT Surgical correction of hypospadias is proposed to improve the aesthetic and functional quality of the penis. Hormone therapy preceding surgical correction is indicated to obtain better surgical conditions. However, there is divergence in the literature regarding the hormone therapy of choice, time of its use before surgery, appropriate dose, and route of application. To try to elucidate this matter, an electronic survey of the databases PubMed and Cochrane Central Library was conducted, limited to articles in English published since 1980. Search strategy identified 14 clinical trials that matched the inclusion criteria. Analysis was made in terms of study design, classification of hypospadias, association with chordee and cryptorchidism, type of hormone, route of application, dose and duration of treatment, penile length before and after hormone therapy, glans circumference before and after hormone therapy, adverse effects, and surgical complications. From the trials evaluated it was not possible to determine the ideal neoadjuvant treatment. A preference for use of testosterone was observed. Intramuscular administration seems to have fewer adverse effects than topical treatment. Side effects were seldom described, and treated patients were not followed on a long-term basis. The scarcity of randomized and controlled clinical trials regarding the topic impairs the establishment of a protocol. In conclusion, although preoperative hormone therapy is currently used before hypospadias surgery, its real benefit in terms of improvement of the penis and surgical results has not been defined.

Download full-text

Full-text

Available from: José Murillo Bastos Netto, Dec 17, 2013
1 Follower
 · 
199 Views
  • Source
    • "Our study focused on the use of preoperative testosterone ; however, alternative hormonal therapies have been suggested including human chorionic gonadotropin (HCG) and (DHT). In a recent meta-analysis by Netto et al., alternative hormone therapies were used in 5 out of 14 clinical trials, with the others using only testosterone [11]. Koff and Jayanthi reported the benefit of HCG with an increase in growth of the penile shaft proximal to the urethral meatus and a decrease in severity of chordee [5]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective To better characterize the current state of testosterone use in the surgical correction of hypospadias among pediatric urologists. Methods An email was sent via the pedsurologyresearch listserv through the American Academy of Pediatrics, inviting members to participate in an anonymous survey regarding their use of preoperative testosterone in hypospadias correction. Results Twenty-seven responses were obtained for a response rate of 53%. Almost all responders practiced in North America, had exclusively pediatric patients in their practice, and had been in practice for 30 years or less. 55% were classified as high-volume surgeons, completing >50 cases yearly, 87% of whom use preoperative androgen therapy currently, compared with 67% of low-volume surgeons. Testosterone was prescribed primarily for a small appearing penis, reduced glans circumference, reduced urethral plate width, and/or proximal hypospadias. The effect of testosterone was determined primarily by evaluating penile appearance (59%). However, the majority (56%) of physicians stopped giving testosterone when they completed a predetermined regimen. Conclusions While many pediatric urologists use testosterone prior to hypospadias repair, the practice patterns are variable. It appears that the use of testosterone is primarily limited to patients with proximal hypospadias, small appearing penis, reduced glans circumference or reduced urethral plate.
    Journal of pediatric urology 03/2014; 10(5). DOI:10.1016/j.jpurol.2014.02.008 · 1.41 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To assess influence of penile biometric characteristics on surgical outcome of tubularized incised plate (TIP) repair for hypospadias. We prospectively studied 42 boys with distal hypospadias that underwent TIP urethroplasty. Biometric assessment prior to surgery consisted of classifying glans shape, urethral plate (UP) length and width, prepuce vascularization and penile size, using a caliper rule, according to previous definitions. Surgical outcome was assessed according to the occurrence of dehiscence, fistula or urethral stricture. There was no statistical difference among groups concerning postoperative complications. Glans shape: grooved (24/57 %), shallow (9/21 %) and conical (9/21 %). UP width: <10 mm (26/62 %) and ≥10 mm (16/38 %). UP length was evaluated in 29 patients: <10 mm in (12/41 %) and ≥10 mm (17/59 %). Prepuce vascularization: one predominant blood vessel (17/41 %), two predominant blood vessels (8/19 %), H-like form with communication between two well-developed blood vessels (6/14 %) and net-like form with no predominant blood vessels (11/26 %). Penile size was measured in 28 patients under 50th percentile (25/89 %). Glans shape, UP width, UP length, prepuce vascularization and penile size do not significantly affect the complication rate of TIP repair in distal hypospadias. Most of the patients with distal hypospadias presented with penile size under mean length for age suggesting some form of mild hypogonadism.
    Pediatric Surgery International 12/2013; 30(3). DOI:10.1007/s00383-013-3442-1 · 1.06 Impact Factor
  • The Journal of Urology 05/2014; 192(2). DOI:10.1016/j.juro.2014.05.007 · 3.75 Impact Factor
Show more